Brinker Capital Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$863K Sell
3,846
-1,024
-21% -$255K 0.01% 1194
2025
Q4
$1.17M Sell
4,870
-2,059
-30% -$527K 0.01% 1155
2025
Q3
$1.9M Sell
6,929
-236
-3% -$64.5K 0.01% 862
2025
Q2
$1.85M Sell
7,165
-106
-1% -$25.3K 0.02% 829
2025
Q1
$1.63M Buy
7,271
+2,660
+58% +$621K 0.02% 813
2024
Q4
$1.05M Sell
4,611
-78
-2% -$18.8K 0.01% 1026
2024
Q3
$1.14M Buy
4,689
+841
+22% +$188K 0.01% 983
2024
Q2
$737K Sell
3,848
-1
-0% -$203 0.01% 1127
2024
Q1
$762K Buy
3,849
+61
+2% +$11.2K 0.01% 1102
2023
Q4
$654K Sell
3,788
-1,615
-30% -$248K 0.01% 1107
2023
Q3
$799K Sell
5,403
-351
-6% -$63.5K 0.01% 1028
2023
Q2
$1.26M Buy
5,754
+24
+0.4% +$5.35K 0.01% 856
2023
Q1
$1.25M Sell
5,730
-8,922
-61% -$1.94M 0.02% 786
2022
Q4
$3.05M Buy
14,652
+8,213
+128% +$1.8M 0.06% 325
2022
Q3
$1.41M Buy
6,439
+236
+4% +$53.7K 0.03% 577
2022
Q2
$1.3M Sell
6,203
-225
-4% -$47.9K 0.02% 650
2022
Q1
$1.56M Buy
6,428
+59
+0.9% +$14.3K 0.02% 634
2021
Q4
$1.66M Buy
6,369
+934
+17% +$242K 0.02% 645
2021
Q3
$1.34M Hold
5,435
0.02% 672
2021
Q2
$1.34M Buy
5,435
+285
+6% +$59.9K 0.02% 727
2021
Q1
$999K Sell
5,150
-4,990
-49% -$1M 0.02% 706
2020
Q4
$2.15M Buy
10,140
+4,463
+79% +$890K 0.03% 535
2020
Q3
$973K Buy
+5,677
New +$1.05M 0.02% 694

Other funds holding RMD

Brinker Capital Investments's RMD Position: Q1 2026 in Review

Brinker Capital Investments reduced its ResMed (RMD) stake by 21% in Q1 2026, selling an estimated $255K and leaving 3,846 shares worth $863K. The position accounts for 0.01% of the portfolio, ranked #1194.

Brinker Capital Investments first reported a position in RMD in Q3 2020 and has held it in 23 quarters since. The position peaked at $3.05M in Q4 2022. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Brinker Capital Investments held 3,846 shares of ResMed worth $863K as of Q1 2026.
  • Brinker Capital Investments sold 1,024 ResMed shares in Q1 2026, an estimated $255K.
  • ResMed made up 0.01% of Brinker Capital Investments's portfolio in Q1 2026, its #1194 holding.
  • Brinker Capital Investments first reported a position in ResMed in Q3 2020 and has held it in 23 quarters since.
  • Brinker Capital Investments's ResMed position peaked at $3.05M in Q4 2022.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.